Your browser doesn't support javascript.
loading
Genetic inhibition of hepatic acetyl-CoA carboxylase activity increases liver fat and alters global protein acetylation.
Chow, Jenny D Y; Lawrence, Robert T; Healy, Marin E; Dominy, John E; Liao, Jason A; Breen, David S; Byrne, Frances L; Kenwood, Brandon M; Lackner, Carolin; Okutsu, Saeko; Mas, Valeria R; Caldwell, Stephen H; Tomsig, Jose L; Cooney, Gregory J; Puigserver, Pere B; Turner, Nigel; James, David E; Villén, Judit; Hoehn, Kyle L.
Afiliación
  • Chow JD; Department of Pharmacology, University of Virginia, Charlottesville, VA 22908, USA.
  • Lawrence RT; Department of Genome Sciences, University of Washington, Seattle, WA 98195, USA.
  • Healy ME; Department of Pharmacology, University of Virginia, Charlottesville, VA 22908, USA.
  • Dominy JE; Department of Cancer Biology, Dana-Faber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA ; Department of Cell Biology, Dana-Faber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA.
  • Liao JA; Department of Pharmacology, University of Virginia, Charlottesville, VA 22908, USA.
  • Breen DS; Department of Pharmacology, University of Virginia, Charlottesville, VA 22908, USA.
  • Byrne FL; Department of Pharmacology, University of Virginia, Charlottesville, VA 22908, USA.
  • Kenwood BM; Department of Pharmacology, University of Virginia, Charlottesville, VA 22908, USA.
  • Lackner C; Institute of Pathology, Medical University Graz, Graz, Austria.
  • Okutsu S; Department of Pharmacology, University of Virginia, Charlottesville, VA 22908, USA.
  • Mas VR; Department of Medicine, University of Virginia, Charlottesville, VA 22908, USA.
  • Caldwell SH; Department of Medicine, University of Virginia, Charlottesville, VA 22908, USA.
  • Tomsig JL; Department of Pharmacology, University of Virginia, Charlottesville, VA 22908, USA.
  • Cooney GJ; Diabetes and Obesity Program, Garvan Institute of Medical Research, Darlinghurst, NSW 2010, Australia.
  • Puigserver PB; Department of Cancer Biology, Dana-Faber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA ; Department of Cell Biology, Dana-Faber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA.
  • Turner N; Department of Pharmacology, School of Medical Sciences, University of New South Wales, Sydney, Australia.
  • James DE; Diabetes and Obesity Program, Garvan Institute of Medical Research, Darlinghurst, NSW 2010, Australia.
  • Villén J; Department of Genome Sciences, University of Washington, Seattle, WA 98195, USA.
  • Hoehn KL; Department of Pharmacology, University of Virginia, Charlottesville, VA 22908, USA ; Department of Medicine, University of Virginia, Charlottesville, VA 22908, USA ; School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, Australia.
Mol Metab ; 3(4): 419-31, 2014 Jul.
Article en En | MEDLINE | ID: mdl-24944901
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Mol Metab Año: 2014 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Mol Metab Año: 2014 Tipo del documento: Article País de afiliación: Estados Unidos